{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:17:13Z","timestamp":1773148633981,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/bf03022250","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T20:24:15Z","timestamp":1241382255000},"page":"S30-S39","source":"Crossref","is-referenced-by-count":95,"title":["The effects of colloid solutions on hemostasis","Les effets des solutions collo\u00efdes sur \u013eh\u00e9mostase"],"prefix":"10.1007","volume":"53","author":[{"given":"Philippe Van der","family":"Linden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte E.","family":"Ickx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03022250_CR1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00003246-199901000-00053","volume":"27","author":"PT Choi","year":"1999","unstructured":"Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27: 200\u201310.","journal-title":"Crit Care Med"},{"key":"BF03022250_CR2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/bja\/84.6.783","volume":"84","author":"J Boldt","year":"2000","unstructured":"Boldt J. Volume replacement in the surgical patient-does the type of solution make a difference? Br J Anaesth 2000; 84: 783\u201393.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1213\/00000539-200210000-00012","volume":"95","author":"P Innerhofer","year":"2002","unstructured":"Innerhofer P, Fries D, Margreiter J, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002; 95: 858\u201365.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/bja\/76.3.412","volume":"76","author":"TG Ruttmann","year":"1996","unstructured":"Ruttmann TG, James FM, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996; 76: 412\u20134.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR5","first-page":"483","volume":"88","author":"C Konrad","year":"1999","unstructured":"Konrad C, Markl T, Schuepfer G, Gerber H, Tschopp M. The effects of in vitro hemodilution with gelatin, hydroxyethyl starch, and lactated Ringer\u2019s solution on markers of coagulation: an analysis using SONOCLOT. Anesth Analg 1999; 88: 483\u20138.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1399-6576.1998.tb05385.x","volume":"42","author":"TT Niemi","year":"1998","unstructured":"Niemi TT, Kuitunen AH. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998; 42: 1104\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"key":"BF03022250_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/bja\/80.5.612","volume":"80","author":"TG Ruttmann","year":"1998","unstructured":"Ruttmann TG, James MF, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200\/0.5) and normal saline on coagulation. Br J Anaesth 1998; 80: 612\u20136.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/bja\/88.4.475","volume":"88","author":"KF Ng","year":"2002","unstructured":"Ng KF, Lam CC, Chan LC. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 2002; 88: 475\u201380.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1213\/00000539-200302000-00012","volume":"96","author":"SB Jones","year":"2003","unstructured":"Jones SB, Whitten CW, Despotis GJ, Monk TG. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg 2003; 96: 363\u20138.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/bja\/88.4.470","volume":"88","author":"TG Ruttmann","year":"2002","unstructured":"Ruttmann TG. Haemodilution enhances coagulation. Br J Anaesth 2002; 88: 470\u20132.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR11","first-page":"113","volume-title":"H\u00e9morragies et Thromboses P\u00e9riop\u00e9ratoires: Approche Pratique","author":"B Ouaknine-Orlando","year":"2000","unstructured":"Ouaknine-Orlando B, Samama CM. H\u00e9matocrite et h\u00e9mostase.In: Samama CM, de Moerloose P, Hardy JF, Si\u00e9 P,Steib A (Eds). H\u00e9morragies et Thromboses P\u00e9riop\u00e9ratoires: Approche Pratique. Paris: Masson; 2000: 113\u20139."},{"key":"BF03022250_CR12","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00003246-200106000-00038","volume":"29","author":"E Jonge de","year":"2001","unstructured":"de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001; 29: 1261\u20137.","journal-title":"Crit Care Med"},{"key":"BF03022250_CR13","first-page":"51","volume-title":"H\u00e9morragies et Thromboses P\u00e9riop\u00e9ratoires: Approche Pratique","author":"JP Carteaux","year":"2000","unstructured":"Carteaux JP, Nathan N. Type de chirurgie et h\u00e9mostase.In: Samama CM, de Moerloose P, Hardy JF, Si\u00e9 P, Steib A (Eds.). H\u00e9morragies et Thromboses P\u00e9riop\u00e9ratoires: Approche Pratique. Paris: Masson; 2000: 51\u201362."},{"key":"BF03022250_CR14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1213\/00000539-200103000-00001","volume":"92","author":"CM Samama","year":"2001","unstructured":"Samama CM. Thromboelastography: the next step. Anesth Analg 2001; 92: 563\u20134.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR15","first-page":"59","volume-title":"Plasma Volume Expansion","author":"MJ London","year":"1992","unstructured":"London MJ. Pharmacology of human albumin.In: Baron JF (Ed.). Plasma Volume Expansion. Paris: Arnette; 1992: 59\u201365."},{"key":"BF03022250_CR16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1010-7940(96)01059-7","volume":"11","author":"I Tigchelaar","year":"1997","unstructured":"Tigchelaar I, Gallandat Huet RC, Korsten J, Boonstra PW, van Oeveren W. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg 1997; 11: 626\u201332.","journal-title":"Eur J Cardiothorac Surg"},{"key":"BF03022250_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-2007-1002409","volume":"18","author":"DK Galanakis","year":"1992","unstructured":"Galanakis DK. Anticoagulant albumin fragments that bind to fibrinogen\/fibrin: possible implications. Semin Thromb Hemost 1992; 18: 44\u201352.","journal-title":"Semin Thromb Hemost"},{"key":"BF03022250_CR18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00003246-199404000-00016","volume":"22","author":"S Kapiotis","year":"1994","unstructured":"Kapiotis S, Quehenberger P, Eichler HG, et al. Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med 1994; 22: 606\u201312.","journal-title":"Crit Care Med"},{"key":"BF03022250_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/bja\/82.2.175","volume":"82","author":"S Karoutsos","year":"1999","unstructured":"Karoutsos S, Nathan N, Lahrimi A, Grouille D, Feiss P, Cox DJ. Thrombelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 1999; 82: 175\u20137.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/bja\/78.6.684","volume":"78","author":"GA Egli","year":"1997","unstructured":"Egli GA, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 1997; 78: 684\u20139.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1213\/00000539-199202000-00008","volume":"74","author":"J Boldt","year":"1992","unstructured":"Boldt J, Zickmann B, Ballesteros BM, Stertmann F, Hempelmann G. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anesth Analg 1992; 74: 219\u201325.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1213\/00000539-199608000-00011","volume":"83","author":"NH Vogt","year":"1996","unstructured":"Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Large-dose administration of 6% hydroxyethyl starch 200\/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996; 83: 262\u20138.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2044.1999.00649.x","volume":"55","author":"N Vogt","year":"1999","unstructured":"Vogt N, Bothner U, Brinkmann A, de Petriconi R, Georgieff M. Peri-operative tolerance to large-dose 6% HES 200\/0.5 in major urological procedures compared with 5% human albumin. Anaesthesia 1999; 55: 121\u20137.","journal-title":"Anaesthesia"},{"key":"BF03022250_CR24","first-page":"75","volume-title":"Plasma Volume Expansion","author":"H Laubenthal","year":"1992","unstructured":"Laubenthal H, Messmer K. Pharmacology of dextrans.In: Baron JF (Ed.). Plasma Volume Expansion. Paris: Arnette; 1992: 75\u201383."},{"key":"BF03022250_CR25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-6576.1998.tb05099.x","volume":"42","author":"GC Kramer","year":"1998","unstructured":"Kramer GC, Wade CE, Prough DS. Hypertonic saline dextran: efficacy and regulatory approval. Acta Anaesthesiol Scand 1998; 42: 141\u20134.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"BF03022250_CR26","doi-asserted-by":"crossref","first-page":"531S","DOI":"10.1378\/chest.114.5_Supplement.531S","volume":"114","author":"GP Clagett","year":"1998","unstructured":"Clagett GP, Anderson FA Jr, Geerts W, et al. Prevention of venous thromboembolism. Chest 1998; 114(5 Suppl): 531S-60.","journal-title":"Chest"},{"key":"BF03022250_CR27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1055\/s-0038-1660100","volume":"54","author":"J Batlle","year":"1985","unstructured":"Batlle J, del Rio F, Lopez Fernandez MF, Martin R, Lopez Borrasca A. Effect of dextran on factor VIII\/von Willebrand factor structure and function. Thromb Haemost 1985; 54: 697\u20139.","journal-title":"Thromb Haemost"},{"key":"BF03022250_CR28","first-page":"97","volume-title":"Plasma Volume Expansion","author":"CM Samama","year":"1992","unstructured":"Samama CM. Dextan and hemostasis.In: Baron JF (Ed.). Plasma Volume Expansion. Paris: Arnette; 1992: 97\u2013104."},{"key":"BF03022250_CR29","first-page":"633","volume":"148","author":"D Bergqvist","year":"1982","unstructured":"Bergqvist D. Dextran and haemostasis. A review. Acta Chir Scand 1982; 148: 633\u201340.","journal-title":"A review. Acta Chir Scand"},{"key":"BF03022250_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-6576.1995.tb04036.x","volume":"39","author":"M Eriksson","year":"1995","unstructured":"Eriksson M, Saldeen T. Effect of dextran on plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) during surgery. Acta Anaesthesiol Scand 1995; 39: 163\u20136.","journal-title":"Acta Anaesthesiol Scand"},{"key":"BF03022250_CR31","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/11024150152619264","volume":"167","author":"G Alberth","year":"2001","unstructured":"Alberth G, Kettisen J, Lisander B. Blood loss in prosthetic hip replacement is not influenced by the ABO blood group. Eur J Surg 2001; 167: 652\u20135.","journal-title":"Eur J Surg"},{"key":"BF03022250_CR32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0049-3848(91)90009-L","volume":"62","author":"PA Flordal","year":"1991","unstructured":"Flordal PA, Svensson J, Ljungstrom KG. Effects of desmopressin and dextran on coagulation and fibrinolysis in healthy volunteers. Thromb Res 1991; 62: 355\u201364.","journal-title":"Thromb Res"},{"key":"BF03022250_CR33","first-page":"67","volume-title":"Plasma Volume Expansion","author":"P Linden Van der","year":"1992","unstructured":"Van der Linden P, Schmartz D. Pharmacology of gelatins.In: Baron JF (Ed.). Plasma Volume Expansion. Paris: Arnette; 1992: 67\u201374."},{"key":"BF03022250_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-0037-1614979","volume":"79","author":"E Jonge de","year":"1998","unstructured":"de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998; 79: 286\u201390.","journal-title":"Thromb Haemost"},{"key":"BF03022250_CR35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1055\/s-0038-1649963","volume":"74","author":"N Tabuchi","year":"1995","unstructured":"Tabuchi N, de Haan J, Gallandat Huet RC, Boonstra PW, van Oeveren W. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 1995; 74: 1447\u201351.","journal-title":"Thromb Haemost"},{"key":"BF03022250_CR36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/bja\/81.2.198","volume":"81","author":"PA Evans","year":"1998","unstructured":"Evans PA, Glenn JR, Heptinstall S, Madira W. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 1998; 81: 198\u2013202.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bja\/80.2.204","volume":"80","author":"SN Mardel","year":"1998","unstructured":"Mardel SN, Saunders FM, Allen H, et al. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 1998; 80: 204\u20137.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1365-2044.1997.220-az0354.x","volume":"52","author":"E Mortier","year":"1997","unstructured":"Mortier E, Ongenae M, De Baerdemaeker L, et al. In vitro evaluation of the effect of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4%, and dextran 40 10% on coagulation profile measured by thromboelastography. Anaesthesia 1997; 52: 1061\u20134.","journal-title":"Anaesthesia"},{"key":"BF03022250_CR39","first-page":"1235","volume":"81","author":"YJ Mortelmans","year":"1995","unstructured":"Mortelmans YJ, Vermaut G, Verbruggen AM, et al. Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Anesth Analg 1995; 81: 1235\u201342.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/bja\/82.4.503","volume":"82","author":"P Hobisch-Hagen","year":"1999","unstructured":"Hobisch-Hagen P, Wirleitner B, Mair J, et al. Consequences of acute normovolaemic haemodilution on haemostasis during major orthopaedic surgery. Br J Anaesth 1999; 82: 503\u20139.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s001340050833","volume":"25","author":"J Treib","year":"1999","unstructured":"Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25: 258\u201368.","journal-title":"Intensive Care Med"},{"key":"BF03022250_CR42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1537-2995.1996.36596282590.x","volume":"36","author":"J Treib","year":"1996","unstructured":"Treib J, Haass A, Pindur G, Grauer MT, Wenzel E, Schimrigk K. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996; 36: 450\u20135.","journal-title":"Transfusion"},{"key":"BF03022250_CR43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00044011-199816020-00008","volume":"16","author":"J Waitzinger","year":"1998","unstructured":"Waitzinger J, Bepperling F, Pabst G, Opitz J, Muller M, Baron JF. Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130\/.04)] after single-dose infusion of 6% or 10% solutions in healthy volunteers. Clin Drug Invest 1998; 16: 151\u201360.","journal-title":"Clin Drug Invest"},{"key":"BF03022250_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00126839-200405010-00001","volume":"5","author":"C Jungheinrich","year":"2004","unstructured":"Jungheinrich C, Sauermann W, Bepperling F, Vogt NH. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130\/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study. Drugs R D 2004; 5: 1\u20139.","journal-title":"Drugs R D"},{"key":"BF03022250_CR45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0750-7658(97)80189-X","volume":"17","author":"J Treib","year":"1998","unstructured":"Treib J, Baron JF. Hydroxyethyl starch: effects on hemostasis. Ann Fr Anesth R\u00e9anim 1998; 17: 72\u201381.","journal-title":"Ann Fr Anesth R\u00e9anim"},{"key":"BF03022250_CR46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1537-2995.1985.25485273815.x","volume":"25","author":"DC Stump","year":"1985","unstructured":"Stump DC, Strauss RG, Henriksen RA, Petersen RE, Saunders R. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985; 25: 349\u201354.","journal-title":"Transfusion"},{"key":"BF03022250_CR47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1537-2995.2002.00003.x","volume":"42","author":"RG Strauss","year":"2002","unstructured":"Strauss RG, Pennell BJ, Stump DC. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 2002; 42: 27\u201336.","journal-title":"Transfusion"},{"key":"BF03022250_CR48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0009-9120(99)00014-4","volume":"32","author":"MN Omar","year":"1999","unstructured":"Omar MN, Shouk TA, Khaleq MA. Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement. Clin Biochem 1999; 32: 269\u201374.","journal-title":"Clin Biochem"},{"key":"BF03022250_CR49","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00000539-200104000-00011","volume":"92","author":"O Langeron","year":"2001","unstructured":"Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130\/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200\/0.5. Anesth Analg 2001; 92: 855\u201362.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR50","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/BF03019870","volume":"47","author":"Huet RC Gallandat","year":"2000","unstructured":"Gallandat Huet RC, Siemons AW, Baus D, et al. A novel hydroxyethy starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000; 47: 1207\u201315.","journal-title":"Can J Anesth"},{"key":"BF03022250_CR51","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00273540","volume":"11","author":"E Macintyre","year":"1985","unstructured":"Macintyre E, Mackie IJ, Ho D, Tinker J, Bullen C, Machin SJ. The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Intensive Care Med 1985; 11: 300\u20133.","journal-title":"Intensive Care Med"},{"key":"BF03022250_CR52","first-page":"408","volume":"14","author":"B Ickx","year":"2002","unstructured":"Ickx B, Van der Linden P. Interactions entre les solut\u00e9s collo\u00efdes et \u013eh\u00e9mostase. STV 2002; 14: 408\u201316.","journal-title":"STV"},{"key":"BF03022250_CR53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/00000539-200002000-00007","volume":"90","author":"CJ Konrad","year":"2000","unstructured":"Konrad CJ, Markl TJ, Schuepfer GK, Schmeck J, Gerber HR. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactate Ringer\u2019s solution on coagulation using SONOCLOT. Anesth Analg 2000; 90: 274\u20139.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR54","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/BF01699231","volume":"22","author":"J Boldt","year":"1996","unstructured":"Boldt J, Muller M, Heesen M, Heyn O, Hempelmann G. Influence of different volume therapies on platelet function in the critically ill. Intensive Care Med 1996; 22: 1075\u201381.","journal-title":"Intensive Care Med"},{"key":"BF03022250_CR55","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/00000539-200106000-00008","volume":"92","author":"A Franz","year":"2001","unstructured":"Franz A, Braunlich P, Gamsjager T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001; 92: 1402\u20137.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR56","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00000539-200010000-00010","volume":"91","author":"B Stogermuller","year":"2000","unstructured":"Stogermuller B, Stark J, Willschke H, Felfernig M, Hoerauf K, Kozek-Langenecker SA. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000; 91: 823\u20137.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR57","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1213\/01.ANE.0000073353.31894.BE","volume":"97","author":"E Deusch","year":"2003","unstructured":"Deusch E, Gamsjager T, Kress HG, Kozek-Langenecker SA. Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003; 97: 680\u20133.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR58","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/00000539-200205000-00043","volume":"94","author":"D Fries","year":"2002","unstructured":"Fries D, Innerhofer P, Klingler A, et al. The effect of the combined administration of colloids and lactated Ringer\u2019s solution on the coagulation system: an in vitro study using thromboelastograph coagulation analysis (ROTEG). Anesth Analg 2002; 94: 1280\u20137.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1213\/00000539-199701000-00037","volume":"84","author":"BB Warren","year":"1997","unstructured":"Warren BB, Durieux ME. Hydroxyethyl starch: safe or not? Anesth Analg 1997; 84: 206\u201312.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR60","first-page":"210","volume":"26","author":"J Treib","year":"1996","unstructured":"Treib J, Haass A, Pindur G, et al. Highly substituted hydroxyethy starch (HES200\/0.62) leads to Type I von Willebrand syndrome after repeated administration. Haemostasis 1996; 26: 210\u20133.","journal-title":"Haemostasis"},{"key":"BF03022250_CR61","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF03019102","volume":"51","author":"PJ Linden Van der","year":"2004","unstructured":"Van der Linden PJ, De Hert SG, Daper A, et al. 3.5% urea-linked gelatin is as effective as 6% HES 200\/0.5 for volume management in cardiac surgery patients. Can J Anesth 2004; 51: 236\u201341.","journal-title":"Can J Anesth"},{"key":"BF03022250_CR62","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","volume":"69","author":"JC Gill","year":"1987","unstructured":"Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691\u20135.","journal-title":"Blood"},{"key":"BF03022250_CR63","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/00000539-200106000-00007","volume":"92","author":"C Huraux","year":"2001","unstructured":"Huraux C, Ankri AA, Eyraud D, et al. Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO group. Anesth Analg 2001; 92: 1396\u2013401.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR64","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000539-200207000-00057","volume":"95","author":"B Lisander","year":"2002","unstructured":"Lisander B, Hahn R. Hemostasis in patients of different ABO blood groups. Anesth Analg 2002; 95: 254\u20135.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR65","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1213\/00000539-199207000-00005","volume":"75","author":"Y Claes","year":"1992","unstructured":"Claes Y, Van Hemelrijck J, Van Cerven M, et al. Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Anesth Analg 1992; 75: 24\u201330.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR66","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1213\/00000539-199610000-00026","volume":"83","author":"JM Conroy","year":"1996","unstructured":"Conroy JM, Fishman RL, Reeves ST, Pinosky ML, Lazarchick J. The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg 1996; 83: 804\u20137.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR67","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1213\/00000539-199905000-00005","volume":"88","author":"TJ Gan","year":"1999","unstructured":"Gan TJ, Bennett-Guerrero E, Phillips-Bute B, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 1999; 88: 992\u20138.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1213\/01.ANE.0000130349.99727.58","volume":"99","author":"E Deusch","year":"2004","unstructured":"Deusch E, Thaler U, Kozek-Langenecker SA. The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 2004; 99: 665\u20138.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR69","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1213\/01.ANE.0000061582.09963.FD","volume":"96","author":"TA Neff","year":"2003","unstructured":"Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130\/0.4 in patients with severe head injury. Anesth Analg 2003; 96: 1453\u20139.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR70","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1213\/00000539-200103000-00003","volume":"92","author":"G Haisch","year":"2001","unstructured":"Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130\/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001; 92: 565\u201371.","journal-title":"Anesth Analg"},{"key":"BF03022250_CR71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/bja\/aef242","volume":"89","author":"J Boldt","year":"2002","unstructured":"Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth 2002; 89: 722\u20138.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/bja\/aeg159","volume":"91","author":"BE Ickx","year":"2003","unstructured":"Ickx BE, Bepperling F, Melot C, Schulman C, Van der Linden PJ. Plasma substitution effects of a new hydroxyethyl starch HES 130\/0.4 compared with HES 200\/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth 2003; 91: 196\u2013202.","journal-title":"Br J Anaesth"},{"key":"BF03022250_CR73","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1034\/j.1399-6576.2003.00220.x","volume":"47","author":"O Sander","year":"2003","unstructured":"Sander O, Reinhart K, Meier-Hellmann A. Equivalence of hydroxyethyl starch HES 130\/0.4 and HES 200\/0.5 for perioperative volume replacement in major gynaecological surgery. Acta Anaesthesiol Scand 2003; 47: 1151\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"key":"BF03022250_CR74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000542-200307000-00010","volume":"99","author":"SM Kasper","year":"2003","unstructured":"Kasper SM, Meinert P, Kampe S, et al. Large-dose hydroxyethyl starch 130\/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200\/0.5 at recommended doses. Anesthesiology 2003; 99: 42\u20137.","journal-title":"Anesthesiology"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"fr","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03022250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03022250\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03022250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T21:19:49Z","timestamp":1633382389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03022250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":74,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["BF03022250"],"URL":"https:\/\/doi.org\/10.1007\/bf03022250","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}